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M. Brandt,* K. Hussel, K.P. Walluscheck, A. Bo¨ning, A. Rahimi and J. CremerDepartment of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, GermanyObjectives. The aim of this analysis was to evaluate our results of open surgery on the descending thoracic aorta as
benchmark to define indications for endovascular treatment.
Methods. Between January 1981 and December 2000, 115 patients underwent replacement of the descending or thoraco-
abdominal aorta. Follow-up to 20 years was complete in 98%.
Results. Early mortality was 19% and paraplegia rate was 7%. Surgery before 1990 and coronary artery disease were
independent predictors for early mortality. Thoraco-abdominal repair and normothermia were independent predictors for
paraplegia. Ten years survival rate was 63%.
Conclusions. Our results confirm that replacement of the descending aorta can be performed today with acceptable low
mortality and morbidity and with consistent exclusion of the aneurysm or dissection. Long-term results of endovascular
stent-grafts in the descending aorta are unclear. In our opinion endovascular stent-grafts should be reserved for high risk
patients, acute dissection or acute aortic rupture.Keywords: Aortic surgery; Aortic dissection; Aneurysm.Introduction
Initial publications in 1948 by Shumacker et al. and in
1950 by Swan et al. of successful repair of descending
aortic aneurysms reported using end-to-end anasto-
mosis or an arterial homograft.1,2 In 1958 DeBakey et
al., commenced using a Dacron prosthesis for repair of
aortic aneurysms.3 Results of descending aortic oper-
ations have improved considerably over the years.
Nevertheless, replacement of the descending aorta
carries a significant risk for mortality and paraplegia.
During the last decade the use of endovascular stent-
grafts for the treatment of aneurysms and dissections
of the descending aorta has becomes more and more
attractive. The aim of this analysis was to establish a
baseline of results and thus, identify the predictors of
early death and paraplegia after open surgery as
benchmark to define indications for endovascular
treatment.ng author. Dr Michael Brandt, MD, Department of
ar Surgery, University Hospital Schleswig-Holstein,
, Arnold-Heller-Strasse 7, 24105 Kiel, Germany.
: mbrandt@kielheart.uni-kiel.de
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Between January 1, 1981, and December 31, 2000, we
operated on 115 patients with descending aortic
aneurysms (including thoraco-abdominal aortic
aneurysms Crawford type I, II and III) or dissections.
In cases of multiple operations in the same patient for
the purpose of statistical analysis, only the first
operation was considered. The patients’ records were
abstracted, and the data were entered into a database
and then checked for accuracy by randomly checking
chart data with data on the computer. Thirty-day
follow-up was complete for all patients. The mean age
of the patients was 57G15 years (range 16–88 years).
Of these, 79 (69%) were male and 36 (31%) were
female. Acute aortic dissection was present in 33 (29%)
patients, and 36 patients (31%) had aortic rupture.
Concurrent medical problems included evidence of
chronic obstructive lung disease in 12 (10%), a history
of coronary artery disease in 26 (23%), and renal
insufficiency in 11 (10%) patients. Coronary artery
disease was defined as historical evidence of myocar-
dial infarction, angina or previous coronary artery
bypass. Renal insufficiency was defined as a history of
previous renal dysfunction, either acute or chronic,
including kidney failure. All preoperative variables
are presented in Table 1.Eur J Vasc Endovasc Surg 30, 365–369 (2005)
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M. Brandt et al.366The operative technique for repair of descending
aortic aneurysms and dissections changed over time.
Whereas in the early years simple clamping was
preferred, in the most recent years all procedures were
performed using extracorporal circulation with mod-
erate or permissive hypothermia and canulation of the
femoral artery. Dacron grafts were used to replace the
diseased aorta. When possible up to three pairs of
intercostal arteries between T9 and L1 were implanted
into the graft. No monitoring of the spinal cord
function or other special strategies for preventing
paraplegia were used in this series.
Operative variables in this study included a mean
total aortic clamp time (defined as reestablishment of
blood flow to the lower limbs) of 59G31 min (range
10–189 min); extracorporal circulation time was 107G
67 min (range 26–360 min). Distal aortic perfusion,
usually by femoral–femoral bypass, was used in 88%
(101/115) of patients. In 15 patients an aortic arch
procedure was performed, mostly a distal hemiarch
replacement. In 40 patients a thoraco-abdominal
approach was used, including different extension of
repairs (Crawford I (nZ15), Crawford II (nZ11),
Crawford III (nZ14)) (Table 2).
Early survival was calculated as 30-day mortality.
Deaths occurring during the non-interrupted post-
operative hospital stay regardless of whether they
were within 30 days or afterwards were also included
in this mortality rate.
Statistical analysis was performed with the SPSS 8.0
statistical software program (SPSS Inc., Chicago, IL,Table 1. Symptoms and co-morbidities
Total, n (%) 1981–1990,
n (%)
1991– 2000,
n (%)
n 115 33 82
Rupture 36 (31%) 12 (36%) 24 (29%)
Preopera-
tive para-
plegia
4 (4%) 2 (7%) 2 (3%)
Hyperten-
sion
62 (54%) 14 (42%) 48 (59%)
Smoking 46 (40%) 9 (27%) 37 (45%)
Peripheral
arterial
occlusive
disease
16 (14%) 1 (3%) 15 (18%) pZ0.026
Coronary
artery dis-
ease
26 (23%) 9 (27%) 17 (21%)
Previous
cardiac
surgery
24 (21%) 4 (12%) 20 (24%)
Pulmonary
disease
12 (10%) 0 12 (15%)
Renal dys-
function
11 (10%) 3 (9%) 8 (10%)
Diabetes
mellitus
2 (2%) 1 (3%) 1 (1%)
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stepwise logistic regression analysis. Twenty-one
preoperative and operative variables were selected
for univariate analysis of their association with 30-day
deaths and postoperative paraplegia or paraparesis:
age, sex, year of surgery, pathology, etiology, rupture,
valve disease, coronary artery disease, left ventricular
function, X-clamp time, ECC time, diabetes, hyperten-
sion, COPD, renal insufficiency, PAOD, lowest tem-
perature, circulatory arrest, use of glue, transfusion of
RBC, preoperative paraplegia. All lower limb neuro-
muscular motor deficits, either immediate or delayed,
that occurred in the hospital were defined as para-
plegia or paraparesis, even when they were unilateral,
unless they were associated with upper limb unilateral
deficits. The latter were considered to be strokes unless
they were also associated with bilateral paraplegia or
paraparesis. Thus, all recorded lower limb deficits that
occurred in hospital were reported.
At discharge after the operation all patients and
their general practioners were informed that follow-up
by CT or MRI is mandatory at regular time intervals
usually at 6 and 12 months and on a yearly basis
thereafter, but not all patients attended routine follow-
up. All patients who had not attended follow-up
during the last 6 months were contacted by phone and
asked to undergo CTorMRI scans. Follow-up ended at
June 30, 2004. Long-term survival and freedom from
re-operation were calculated using Kaplan–Meier life
table methods.Results
The 30-day survival rate over the 20-year period of
study was 81%. The 30-day mortality rate significantly
reduced during the study period with a rate of 13%
during the last 5 years (Fig. 1).
The variables significantly associated with 30-day
death by univariate analysis were coronary artery
disease (pZ0.027), aortic rupture (pZ0.003), emer-
gency operation (pZ0.015), thoraco-abdominal repla-
cement of the aorta (pZ0.054), extracorporal
circulation of more than 120 min (pZ0.003) and
operation date before 1990 (pZ0.049). On multivariate
analysis the factors predictive of 30-day death were
(p!0.002) coronary artery disease and operation date
before 1990.
Postoperative complications included the in-hospi-
tal occurrence of paraplegia or paraparesis in 7% of
patients. During the study period the incidence of
paraplegia reducedwith an incidence of 3% during the
last 5 years (Fig. 2). Paraplegia or paraparesis was
most frequent in thoraco-abdominal aortic
Table 2. Operative data
Total, n (%) 1981–1990,
n (%)
1991–2000,
n (%)
Simple cross-
clamping
14 (12%) 10 (30%) 3 (4%)
ECC 101 (88%) 23 (70%) 79 (96%)
Circulatory
arrest
19 (17%) 2 (6%) 17 (21%)
Normothermia 56 (50%) 25 (78%) 32 (66%)
Aortic arch
procedure
14 (12%) 4 (12%) 10 (12%)
Thoraco-
abdominal
approach
40 (35%) 13 (39%) 27 (33%)
Fig. 2. Changes of the incidence of paraplegia during the
study period.
Replacement of the Descending Aorta 367replacement (20%) compared to descending aortic
replacement (6%).
By univariate analysis predictors of paraplegia of
paraparesis included thoraco-abdominal replacement
of the aorta (pZ0.012), not using extracorporal
circulation (pZ0.010), normothermia (pZ0.001) and
operation date before 1990 (pZ0.04). By multivariate
analysis the factors predictive of paraplegia or para-
paresis were (p!0.006) thoraco-abdominal replace-
ment of the aorta and operation date before 1990.
Other postoperative complications included cer-
ebral insult (4%), intracranial hemorrhage (2%),
pulmonary embolism (1%), pneumonia (4%), renal
failure (6%) and myocardial infarction (4%).
Mean survival time was 56G55 months with long-
term survival of more than 60%. The survival curve is
shown in Fig. 3. Unfortunately, causes of death during
follow-up are unknown in most cases. Follow-up was
98% complete for survival rate and 82% complete for
CT or MRI scans.
In 11 patients (9%) a second operation on the aorta
was necessary during a follow-up of 56G55 months
(12–176 months). Ascending aortic replacement was
performed in two patients, aortic arch replacement inFig. 1. Changes of 30 day-mortality during the study period.one patient and infrarenal aortic replacement in three
patients. In three patients a second operation invol-
ving the descending aorta or the thoraco-abdominal
aorta was performed. One re-operation was per-
formed for false aneurysm. The second operation
was performed 13G14 months after the initial pro-
cedure (Fig. 4). No significant predictors for re-
operation could be detected.Discussion
During the study period 30 day-mortality rate was
reduced from 50% between 1981 and 1985 to 13%
during the last 5 years. Similar results were reported
by other groups with 30 day-survival rates up to 95%.4
However, dependent on the hospital and patient
population 30 day-mortality rates up to 73% for
rupture aneurysms have been reported elsewhere.5Fig. 3. Survival after replacement of the descending aorta.
Eur J Vasc Endovasc Surg Vol 30, October 2005
Fig. 4. Freedom from re-operation.
M. Brandt et al.368Operative techniques have changed during the last 20
years. In the early study period simple clamping was
used in the majority of cases. Today, extracorporal
circulation via cannulation of the femoral artery and
vein is the technique of choice. Similar changes could
be found in the literature.6 Despite this progress
perioperative mortality rate is 13% and significantly
exceeds mortality rates of coronary artery bypass
surgery (3.6%) or valve surgery (4.4%).7 In this patient
cohort coronary artery disease, aortic rupture, emer-
gency operation, thoraco-abdominal aortic replace-
ment, extracorporal circulation time longer than
120 min and operation date before 1990 were pre-
dictors for mortality. Svensson et al. detected an early
operation date and coronary artery disease as risk
factor for early mortality in patients with aortic
dissection.8 Coselli et al. reported thoraco-abdominal
aortic replacement and emergency operation as pre-
dictors for early mortality in Crawford type II-
aneurysms.4 Using extracorporal circulation seems to
reduce hospital mortality rates, but negative effects of
long duration of extracorporal circulation have not
been reported yet.6 The longer time of extracorporal
circulation may reflect the extent of the aortic
pathology and the complex procedure, e.g. under
emergency conditions. Coronary artery disease is also
an independent risk factor in multivariate analysis.
Therefore, detailed cardiological work-up including
cardiac catheterisation and coronary angiography is
indicated in all patients undergoing elective repair of
the descending aorta.9
Thoraco-abdominal aortic replacement carries a
significant risk of paraplegia which is highest in
aneurysms of the Crawford type II.8 Borst and co-
workers were able to show that distal aortic perfusionEur J Vasc Endovasc Surg Vol 30, October 2005can reduce the paraplegia rate.6 This may be due to
perfusion of the spinal cord during the clamping
period by collateral pathways. It is also proven that
reimplantation of intercostal arteries reduces the
incidence of paraplegia. Kouchoukos et al. reported
that hypothermia, especially deep hypothermic circu-
latory arrest, is protective for the spinal cord.10
According to this normothermia is a risk factor in
our patients for developing paraplegia. Operative
procedure before 1990 is also a risk factor in this
study. This may be explained by avoiding extracor-
poral circulation and hypothermia in several patients
in this time period.
In the future a further reduction of paraplegia rates
may be possible using cerebrospinal fluid drainage.
Coselli described a reduction of paraplegia from 13 to
2.6% in thoraco-abdominal aneurysm repair using this
method.11 When comparing our rate of paraplegia of
2.9% during the recent years with the results of Coselli
it has been taken into account that there were only 28%
thoraco-abdominal repairs in our series.
Endoluminal stent-grafts are a relatively new
treatment option in the descending aorta. The prota-
gonists of this method are citing high mortality and
paraplegia rates of standard operation to promote this
new technique using historical data.12 Our data shows
conclusively that there was a significant reduction in
mortality and paraplegia rates during the last 20 years.
Therefore, only operative results of the last 5 years can
be used as benchmark to show advantages of
endoluminal stent-grafting.
In the literature mortality rates up to 12.5% in
elective cases and up to 33% in emergency procedures
are reported for endolumial stent-grafts.13 Paraplegia
rates can be as high as 12% using this new technol-
ogy.13,14 This data shows that endoluminal stent-
grafting is not a risk free procedure. But there were
also reports showing low mortality and paraplegia
rate.15,16
In addition, it should be stated that the standard
operation leads to a durable result with definitive
exclusion of the aneurysm. The incidence of re-
operation was 9% during follow-up to 179 months in
this study, and most of the second procedures have
been performed at another part of the aorta. Whereas
in 29% of patients, who underwent endoluminal stent-
grafting of the descending aorta, an endoleak
appeared.17 Therefore, no definitive exclusion of the
aneurysm has been achieved in these patients with
ongoing risk of rupture.
Also, it is well known that material degeneration of
the stent-grafts can lead to dislocation of the graft.18
This can be followed by graft thrombosis, aortic
perforation or endoleaks. In the infrarenal aorta,
Replacement of the Descending Aorta 369where stent-grafts have been used for a longer time
period compared to the descending aorta, the rate of
re-operation for failure of the stent-graft in the
infrarenal aorta is up to 15%.19 Due to the old
generation of stent-grafts used in this study and due
to the anatomically easier stent-graft placement in the
descending aorta these results may be different in the
descending aorta.
In addition, stent-graft specific complication such as
retrograde aortic dissection must be considered when
comparing stent-graft and standard operation.20–22
Due to significant progress of the results of the
standard operation in recent years endoluminal stent-
grafts should be used only in patients with a high risk
for death or paraplegia using the standard operation.
These are older patients, patients with significant co-
morbidity and patients with acute, complicated type b
dissection or traumatic rupture. Stent-grafting in other
settings should be performed only in randomized,
controlled trials comparing stent-grafting and medical
standard therapy.References
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